First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors
Dienstmann, Rodrigo, Lassen, Ulrik, Cebon, Jonathan, Desai, Jayesh, Brown, Michael P., Evers, Stefan, Su, Fei, Zhang, Weijiang, Boisserie, Frederic, Lestini, Brian, Schostack, Kathleen, Meresse, ValerТом:
11
Мова:
english
Журнал:
Targeted Oncology
DOI:
10.1007/s11523-015-0381-x
Date:
April, 2016
Файл:
PDF, 650 KB
english, 2016